Arieh Greenberg, Doris Braunstein, Nada Read Abughaduma, Allen Gross, Oleg Safir, Paul Kuzyk, Jesse Wolfstadt, David Backstein
{"title":"Survivorship and Complications in Revision Total Knee Arthroplasty with a Constrained Condylar Knee Implant: A Minimum 10-Year Follow-Up Study.","authors":"Arieh Greenberg, Doris Braunstein, Nada Read Abughaduma, Allen Gross, Oleg Safir, Paul Kuzyk, Jesse Wolfstadt, David Backstein","doi":"10.1016/j.arth.2025.05.088","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Constrained condylar knee (CCK) prostheses are commonly used in revision total knee arthroplasty (TKA) for cases requiring increased constraint due to ligamentous insufficiency. However, long-term outcomes remain underreported. This study evaluated the survivorship and complications of CCK implants over a minimum 10-year follow-up, extending up to 23 years.</p><p><strong>Methods: </strong>We retrospectively reviewed 345 revision TKA procedures with CCK implants performed from 2001 to 2014. The cohort included 190 women (55%) and 155 men (45%), with a mean age of 69 years (range, 36 to 92) and a mean follow-up of 13.5 years (range, 10 to 23.3). The primary diagnosis before initial TKA was osteoarthritis (81%). Indications for revision included aseptic loosening (23.2%), infection (22.9%), malrotation/malalignment (14.2%), and instability (13%). Femoral and tibial augments were used in 238 and 62 cases, respectively, while 25 patients required void fillers for bone defects. Kaplan-Meier survival analysis assessed implant longevity, defining failure as revision for any cause and revision due to aseptic loosening.</p><p><strong>Results: </strong>Kaplan-Meier analysis demonstrated favorable long-term survivorship. All-cause revision-free survival was 95.1% (95% CI [confidence interval]: 92.7 to 97.5) at five years and stabilized at 93.6% (95% CI: 91.0 to 96.2) from 10 years onward. Survivorship free from revision due to aseptic loosening was 98.5% (95% CI: 97.1 to 99.9) at five years and 97.9% (95% CI: 96.3 to 99.5) through 20 years. The number of knees at risk declined over time, from 314 at 10 years to 16 at 20 years. There were 25 complications that occurred at a mean of 2.9 years post-revision, with 22 requiring surgical intervention. The most common causes for revision were infection (54.5%) and aseptic loosening (31.8%). Surgical management included revision TKA (n = 7), irrigation and debridement with polyethylene exchange (n = 4), two-stage revision (n = 3), and above-knee amputation (n = 2).</p><p><strong>Conclusion: </strong>The CCK implants demonstrate favorable long-term survivorship in revision TKA at a minimum 10-year follow-up. These findings support the continued use of CCK implants in revision TKA with appropriate patient selection and careful surgical technique.</p>","PeriodicalId":51077,"journal":{"name":"Journal of Arthroplasty","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Arthroplasty","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.arth.2025.05.088","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Constrained condylar knee (CCK) prostheses are commonly used in revision total knee arthroplasty (TKA) for cases requiring increased constraint due to ligamentous insufficiency. However, long-term outcomes remain underreported. This study evaluated the survivorship and complications of CCK implants over a minimum 10-year follow-up, extending up to 23 years.
Methods: We retrospectively reviewed 345 revision TKA procedures with CCK implants performed from 2001 to 2014. The cohort included 190 women (55%) and 155 men (45%), with a mean age of 69 years (range, 36 to 92) and a mean follow-up of 13.5 years (range, 10 to 23.3). The primary diagnosis before initial TKA was osteoarthritis (81%). Indications for revision included aseptic loosening (23.2%), infection (22.9%), malrotation/malalignment (14.2%), and instability (13%). Femoral and tibial augments were used in 238 and 62 cases, respectively, while 25 patients required void fillers for bone defects. Kaplan-Meier survival analysis assessed implant longevity, defining failure as revision for any cause and revision due to aseptic loosening.
Results: Kaplan-Meier analysis demonstrated favorable long-term survivorship. All-cause revision-free survival was 95.1% (95% CI [confidence interval]: 92.7 to 97.5) at five years and stabilized at 93.6% (95% CI: 91.0 to 96.2) from 10 years onward. Survivorship free from revision due to aseptic loosening was 98.5% (95% CI: 97.1 to 99.9) at five years and 97.9% (95% CI: 96.3 to 99.5) through 20 years. The number of knees at risk declined over time, from 314 at 10 years to 16 at 20 years. There were 25 complications that occurred at a mean of 2.9 years post-revision, with 22 requiring surgical intervention. The most common causes for revision were infection (54.5%) and aseptic loosening (31.8%). Surgical management included revision TKA (n = 7), irrigation and debridement with polyethylene exchange (n = 4), two-stage revision (n = 3), and above-knee amputation (n = 2).
Conclusion: The CCK implants demonstrate favorable long-term survivorship in revision TKA at a minimum 10-year follow-up. These findings support the continued use of CCK implants in revision TKA with appropriate patient selection and careful surgical technique.
期刊介绍:
The Journal of Arthroplasty brings together the clinical and scientific foundations for joint replacement. This peer-reviewed journal publishes original research and manuscripts of the highest quality from all areas relating to joint replacement or the treatment of its complications, including those dealing with clinical series and experience, prosthetic design, biomechanics, biomaterials, metallurgy, biologic response to arthroplasty materials in vivo and in vitro.